Motilon Syrup

About Motilon 5 mg/5 ml Syrup

Synovia Pharma PLC. manufactures Motilon, a 5 mg/5 ml syrup. It contains metoclopramide hydrochloride and belongs to the anti-emetic drug class, which is used in the management of nausea and vomiting.

There are 19 brands of Metoclopramide Hydrochloride listed in Bangladesh. 10 of them have a lower unit price than Motilon. The lowest listed price is Motilon 10 mg Tablet at ৳ 0.34 per unit.

What is Motilon 5 mg/5 ml Syrup?

Motilon is a syrup made by Synovia Pharma PLC. Each 5 ml contains 5 mg of metoclopramide hydrochloride. It is classed as an anti-emetic medicine. Metoclopramide works by blocking dopamine receptors and, at higher doses, serotonin receptors in the brain's trigger zone; it also improves movement in the upper gut and increases the tone of the lower esophageal sphincter. Motilon is supplied in a 100 ml bottle. The doctor decides whether it is suitable and how it should be used.

Uses of Motilon

Motilon is used in the management of nausea and vomiting, as an anti-emetic. Metoclopramide, its active ingredient, affects signals in the brain that trigger nausea and helps the upper digestive tract move contents along. The doctor will decide whether this medicine is appropriate for the person's condition and what course to follow.

How to use Motilon

The doctor decides the dose and course of Motilon. The syrup comes in a 5 mg/5 ml strength in a 100 ml bottle. Do not change the amount or stop early without medical advice. If a dose is missed, ask the doctor or pharmacist what to do. Follow any instructions given by the prescriber and read the label carefully before use.

Side effects of Motilon

Some people may notice side effects while using Motilon. The most common ones reported with metoclopramide are a changed sense of taste, headache and tiredness. Other unwanted effects can occur. If any side effect worries you or does not go away, speak to the doctor or pharmacist. Seek medical help promptly if symptoms are severe or unusual.

Safety and precautions

Motilon is not suitable for everyone. It should not be used by people with a history of tardive dyskinesia or a dystonic reaction to metoclopramide, or when stimulating gut movement could be dangerous, such as with bleeding, blockage or perforation in the gut. It is also not for people with pheochromocytoma or similar tumours, epilepsy, or allergy to metoclopramide. Caution is advised in pregnancy and breastfeeding. Tell the doctor about Parkinson's disease, depression or other medicines before starting.

Frequently asked questions

How should Motilon syrup be taken?

The doctor decides the dose and how long Motilon should be taken. The syrup is a 5 mg/5 ml strength in a 100 ml bottle. Follow the prescriber's instructions and ask the doctor or pharmacist if anything is unclear. Do not change the dose on your own.

Is Motilon safe in pregnancy or breastfeeding?

Metoclopramide is classified as pregnancy category B, but there are no adequate, well-controlled studies in pregnant women. It is excreted in human milk. Motilon should be used in pregnancy or breastfeeding only if the doctor decides it is clearly needed. Ask the doctor before using it.

What does the generic name metoclopramide hydrochloride mean?

Metoclopramide hydrochloride is the active ingredient in Motilon. It is an anti-emetic that blocks dopamine receptors and, at higher doses, serotonin receptors in the brain's trigger zone. It also helps the upper gut move contents and increases lower esophageal sphincter tone.

What is the price of Motilon?

The listed price is ৳ 15.83.

Indications

Metoclopramide nasal spray: This is a dopamine-2 (D2) antagonist indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.

Metoclopramide tablet:
  • This is indicated in the treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy.
  • ... Read more
Metoclopramide nasal spray: This is a dopamine-2 (D2) antagonist indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.

Metoclopramide tablet:
  • This is indicated in the treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy.
  • Relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
Metoclopramide Injection:
  • Diabetic Gastroparesis (Diabetic Gastric Stasis): Metoclopramide Injection is indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis.
  • The Prevention of Nausea and Vomiting Associated with Emetogenic Cancer Chemotherapy: Metoclopramide Injection is indicated for the prophylaxis of vomiting associated with emetogenic cancer chemotherapy.
  • The Prevention of Postoperative Nausea and Vomiting: Metoclopramide Injection is indicated for the prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable.
  • Small Bowel Intubation: Metoclopramide Injection may be used to facilitate small bowel intubation in adults and pediatric patients in whom the tube does not pass the pylorus with conventional maneuvers.
  • Radiological Examination: Metoclopramide Injection may be used to stimulate gastric emptying and intestinal transit of barium in cases where delayed emptying interferes with radiological examination of the stomach and/or small intestine.

Pharmacology

Metoclopramide blocks dopamine receptors and in higher doses, it also blocks serotonin receptors in chemoreceptor trigger zone of the CNS. It enhances the response to acetylcholine of tissue in upper GI tract causing enhanced motility and accelerated gastric emptying w/o stimulating gastric, biliary, or pancreatic secretions. It also increases lower esophageal sphincter tone.

Dosage & Administration

Metoclopramide Spray:

Adults less than 65 years of age: The recommended dosage is 1 spray (15 mg) in one nostril, 30 minutes before each meal and at bedtime (maximum of 4 sprays daily) for 2 to 8 weeks, depending on symptomatic response.

Adults 65 years of age and older: Metoclopramide is not recommended in geriatric patients as initial therapy. Geriatric patients receiving an alternative metoclopramide product at a stable dosage of 10 mg four times daily can be switched to Metoclopramide 1 spray (15 mg) in one nostril, 30 minutes before each meal and at bedtime (maximum four times daily) for 2 to 8 weeks, depending on symptomatic response.

Metoclopramide tablet:

Gastroesophageal Reflux: Administer Metoclopramide continuously or intermittently:
  • Continuous: Administer 10 to 15 mg, 30 minutes before each meal and at bedtime (maximum of 60 mg per day) for 4 to 12 weeks.
  • Intermittent: Single doses up to 20 mg prior to provoking situation.
Acute and Recurrent Diabetic Gastroparesis: Administer 10 mg, 30 minutes before each meal and at bedtime (maximum of 40 mg per day) for 2 to 8 weeks.

Metoclopramide injection:

For the Relief of Symptoms Associated with Diabetic Gastroparesis (Diabetic Gastric Stasis): If only the earliest manifestations of diabetic gastric stasis are present, oral administration of metoclopramide may be initiated. However, if severe symptoms are present, therapy should begin with Metoclopramide Injection (IM or IV). Doses of 10 mg may be administered slowly by the intravenous route over a 1- to 2-minute period. Administration of Metoclopramide Injection (metoclopramide injection, USP) up to 10 days may be required before symptoms subside, at which time oral administration of metoclopramide may be instituted. The physician should make a thorough assessment of the risks and benefits prior to prescribing further metoclopramide treatment.

For the Prevention of Nausea and Vomiting Associated with Emetogenic Cancer Chemotherapy: Intravenous infusions should be made slowly over a period of not less than 15 minutes, 30 minutes before beginning cancer chemotherapy and repeated every 2 hours for two doses, then every 3 hours for three doses. The initial two doses should be 2 mg/kg if highly emetogenic drugs such as cisplatin or dacarbazine are used alone or in combination. For less emetogenic regimens, 1 mg/kg per dose may be adequate.

For the Prevention of Postoperative Nausea and Vomiting: Metoclopramide Injection should be given intramuscularly near the end of surgery. The usual adult dose is 10 mg; however, doses of 20 mg may be used.

Contraindications

Metoclopramide is contraindicated:
  • In patients with a history of tardive dyskinesia (TD) or a dystonic reaction to metoclopramide.
  • When stimulation of gastrointestinal motility might be dangerous (e.g., in the presence of gastrointestinal hemorrhage, mechanical obstruction, or perforation).
  • In patients with pheochromocytoma or other catecholamine-releasing paragangliomas. Reglan may cause a hypertensive/pheochromocytoma crisis, probably due to release of catecholamines from the tumor.
  • In patients with epilepsy. Reglan may increase the frequency and severity of seizures.
  • In patients with hypersensitivity to metoclopramide. Reactions have included laryngeal and glossal angioedema and bronchospasm.

Side Effects

Most common adverse reactions (≥5%) are: dysgeusia, headache, and fatigue.

Pregnancy & Lactation

Pregnancy Category B. Reproduction studies performed in rats, mice and rabbits by the IM, IV, subcutaneous (SC), and oral routes at maximum levels ranging from 12 to 250 times the human dose have demonstrated no impairment of fertility or significant harm to the fetus due to metoclopramide. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Nursing Mothers: Metoclopramide is excreted in human milk. Caution should be exercised when metoclopramide is administered to a nursing mother.

Precautions & Warnings

Tardive Dyskinesia (TD), Other Extrapyramidal Symptoms (EPS), and Neuroleptic Malignant Syndrome (NMS): Avoid concomitant use of other drugs known to cause TD/EPS/NMS and avoid use in patients with Parkinson’s Disease. If symptoms occur, discontinue Reglan and seek immediate medical attention.  

Depression and suicidal ideation/suicide: Avoid use.

Storage Conditions

Store between 20-25°C. Protect from light.

Alternative brands of Metoclopramide Hydrochloride

Other brands with the same generic name, cheapest first.

See all 19 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.